Time filter

Source Type

Belo Horizonte, Brazil

Universidade Federal de Minas Gerais is a federal university located in Belo Horizonte, state of Minas Gerais, Brazil. UFMG is one of Brazil's five largest universities, being the largest federal university. It offers 75 undergraduate degrees, including a Medicine degree, Law and Economics, plus Engineering and Science and Art degrees. It offers 57 PhD programs, 66 MSc programs, 79 Post-Baccalaureate programs and 38 medical internship programs. UFMG has a population of 49,254 students.The undergratuate students are admitted through the national biannual exams called Unified Selection System . Its undergraduate courses were ranked in 1st place in the 2007 results for the National Student's Performance Exam and 4th place in the 2008 results. Its Computer Science course was considered the best in the country, as well the Social science course, from FAFICH by the latest edition of ENADE.The rector of UFMG is Clelio Campolina Diniz. Past students include former Brazilian presidents Juscelino Kubitschek and Tancredo Neves; writer, medical doctor and diplomat João Guimarães Rosa, writers Fernando Sabino, Pedro Nava and Cyro dos Anjos; plastic surgeon Ivo Pitanguy, poet Carlos Drummond de Andrade and musicians Fernando Brant, Samuel Rosa of Skank and Fernanda Takai of Pato Fu.UFMG is the tenth in the rankings of best universities in Latin America, according QS World University Rankings . As reported by the Academic Ranking of World Universities , UFMG is one of the five best universities in Brazil in 2013, and in the World Rank is in the range of 301-400 best universities. Wikipedia.

Federal University of Pará, Federal University of Minas Gerais, Museu Paraense Emilio Goeldi, Instituto Evandro Chagas and Secretaria Executiva De Saude Publica Do Estado Do Para | Date: 2013-05-13

The present invention describes the obtaining process of the dichloromethane fraction and subfractions from

The present invention relates to a pharmaceutical composition for treating visceral leishmaniasis, characterized in that it comprises the association of conventional liposomes and prolonged-circulation liposomes with a leishmanicidal-drug delivery system. Said composition may be used in the preparation of a medicinal product for treating leishmaniasis and may be administered intramuscularly, subcutaneously, intraperitoneally or intravenously. The use of this system enables the drug efficiently to reach all sites infected by the parasite, the pegylated liposomes promoting more effective targeting of the leishmanicidal drugs on the bone marrow and spleen, whilst the conventional liposomes contribute to the targeting of the drug on the liver.

Federal University of Minas Gerais | Date: 2014-05-27

The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of

AS Engineering E CONSULTORIA LTDA. and Federal University of Minas Gerais | Date: 2013-05-29

The present invention discloses a method for preparing and using an absorbent material for apolar compounds or mixtures of apolar compounds, such as organic solvents, mineral oil and derivatives thereof, lubricant oils, edible oils, inter alia. The absorbent material is composed of an fabric matrix of high porosity, low density and high mechanical resistance. This matrix is rendered water-proof, thus acquiring the property of absorbing apolar compounds or mixtures of apolar compounds.

The present invention discloses formulations for the treatment and prevention of alopecia; the formulations comprise angiotensin-(1-7) and/or their analogues, encapsulated in ultradeformable vesicles prepared from specific combinations of phospholipids and surfactants, which confer efficacy to topical application in the control of hair growth, which indicates their great potential for the prevention and treatment of alopecia. The invention also describes formulations containing A779 Mas receptor antagonist of angiotensin-(1-7) and/or their analogues and their use in inhibiting hair growth.

Discover hidden collaborations